4.連結財務諸表及び主な注記
(1)連結貸借対照表
| | (単位:百万円) |
| 前連結会計年度 (2025年9月30日) | 当連結会計年度 (2026年9月30日) |
資産の部 | | |
流動資産 | | |
現金及び預金 | 26,930 | 25,667 |
受取手形及び売掛金 | 12,110 | 11,310 |
商品及び製品 | 5,974 | 7,866 |
仕掛品 | 183 | 174 |
原材料及び貯蔵品 | 1,525 | 1,665 |
その他 | 2,166 | 2,630 |
貸倒引当金 | △7 | △7 |
流動資産合計 | 48,884 | 49,307 |
固定資産 | | |
有形固定資産 | | |
建物及び構築物(純額) | 4,419 | 4,057 |
機械装置及び運搬具(純額) | 547 | 469 |
土地 | 14,976 | 14,488 |
リース資産(純額) | 686 | 613 |
建設仮勘定 | 545 | 822 |
その他(純額) | 221 | 257 |
有形固定資産合計 | ※1 21,397 | ※1 20,709 |
無形固定資産 | | |
のれん | 125 | 91 |
ソフトウエア | 89 | 789 |
その他 | 969 | 122 |
無形固定資産合計 | 1,184 | 1,002 |
投資その他の資産 | | |
投資有価証券 | 2,866 | 2,578 |
繰延税金資産 | 1,070 | 1,124 |
その他 | 1,106 | 740 |
貸倒引当金 | △17 | △15 |
投資その他の資産合計 | 5,026 | 4,428 |
固定資産合計 | 27,608 | 26,140 |
資産合計 | 76,492 | 75,448 |
| | (単位:百万円) |
| 前連結会計年度 (2025年9月30日) | 当連結会計年度 (2026年9月30日) |
負債の部 | | |
流動負債 | | |
支払手形及び買掛金 | 3,240 | 2,887 |
リース債務 | 85 | 85 |
未払金 | 2,160 | 2,133 |
未払法人税等 | 2,043 | 1,560 |
賞与引当金 | 25 | 4 |
その他 | 2,290 | 2,243 |
流動負債合計 | 9,847 | 8,914 |
固定負債 | | |
リース債務 | 657 | 579 |
長期預り保証金 | 10,751 | 10,356 |
繰延税金負債 | 690 | 731 |
その他 | 336 | 236 |
固定負債合計 | 12,436 | 11,903 |
負債合計 | 22,283 | 20,817 |
純資産の部 | | |
株主資本 | | |
資本金 | 7,319 | 7,319 |
利益剰余金 | 44,113 | 44,473 |
自己株式 | △2 | △2 |
株主資本合計 | 51,429 | 51,790 |
その他の包括利益累計額 | | |
その他有価証券評価差額金 | 1,751 | 1,584 |
為替換算調整勘定 | 585 | 781 |
その他の包括利益累計額合計 | 2,337 | 2,365 |
非支配株主持分 | 441 | 474 |
純資産合計 | 54,209 | 54,630 |
負債純資産合計 | 76,492 | 75,448 |
E2499149280株式会社ノエビアホールディングスNoevir Holdings Co., Ltd.通期第1号参考様式 [日本基準](連結)Japan GAAPtrueCTECTE2025-10-012026-09-30FY2026-09-302024-10-012025-09-302025-09-301falsefalsefalse492802024-09-30492802024-10-012025-09-30492802025-09-30492802025-10-012026-09-30492802026-09-30492802026-11-10492802024-09-30jppfs_cor:ShareholdersEquityMember492802024-09-30jppfs_cor:CapitalStockMember492802024-09-30jppfs_cor:RetainedEarningsMember492802024-09-30jppfs_cor:TreasuryStockMember492802024-09-30jppfs_cor:ValuationAndTranslationAdjustmentsMember492802024-09-30jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember492802024-09-30jppfs_cor:ForeignCurrencyTranslationAdjustmentMember492802024-09-30jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember492802024-09-30jppfs_cor:NonControllingInterestsMember492802024-10-012025-09-30jppfs_cor:ShareholdersEquityMember492802024-10-012025-09-30jppfs_cor:CapitalStockMember492802024-10-012025-09-30jppfs_cor:RetainedEarningsMember492802024-10-012025-09-30jppfs_cor:TreasuryStockMember492802024-10-012025-09-30jppfs_cor:ValuationAndTranslationAdjustmentsMember492802024-10-012025-09-30jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember492802024-10-012025-09-30jppfs_cor:ForeignCurrencyTranslationAdjustmentMember492802024-10-012025-09-30jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember492802024-10-012025-09-30jppfs_cor:NonControllingInterestsMember492802025-09-30jppfs_cor:ShareholdersEquityMember492802025-09-30jppfs_cor:CapitalStockMember492802025-09-30jppfs_cor:RetainedEarningsMember492802025-09-30jppfs_cor:TreasuryStockMember492802025-09-30jppfs_cor:ValuationAndTranslationAdjustmentsMember492802025-09-30jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember492802025-09-30jppfs_cor:ForeignCurrencyTranslationAdjustmentMember492802025-09-30jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember492802025-09-30jppfs_cor:NonControllingInterestsMember492802025-10-012026-09-30jppfs_cor:ShareholdersEquityMember492802026-09-30jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember492802026-09-30jpcrp_cor:UnallocatedAmountsAndEliminationMember492802024-10-012025-09-30tse-acedjpfr-49280:CosmeticsReportableSegmentsMember492802024-10-012025-09-30tse-acedjpfr-49280:MedicineAndGroceryReportableSegmentsMember492802025-09-30tse-acedjpfr-49280:CosmeticsReportableSegmentsMember492802025-09-30tse-acedjpfr-49280:MedicineAndGroceryReportableSegmentsMember492802025-10-012026-09-30tse-acedjpfr-49280:CosmeticsReportableSegmentsMember492802025-10-012026-09-30tse-acedjpfr-49280:MedicineAndGroceryReportableSegmentsMember492802026-09-30tse-acedjpfr-49280:CosmeticsReportableSegmentsMember492802026-09-30tse-acedjpfr-49280:MedicineAndGroceryReportableSegmentsMember492802024-10-012025-09-30jpcrp_cor:TotalOfReportableSegmentsAndOthersMember492802024-10-012025-09-30jpcrp_cor:ReconcilingItemsMember492802025-09-30jpcrp_cor:TotalOfReportableSegmentsAndOthersMember492802025-09-30jpcrp_cor:ReconcilingItemsMember492802025-10-012026-09-30jpcrp_cor:TotalOfReportableSegmentsAndOthersMember492802025-10-012026-09-30jpcrp_cor:ReconcilingItemsMember492802026-09-30jpcrp_cor:TotalOfReportableSegmentsAndOthersMember492802026-09-30jpcrp_cor:ReconcilingItemsMember492802025-10-012026-09-30jppfs_cor:CapitalStockMember492802025-10-012026-09-30jppfs_cor:RetainedEarningsMember492802025-10-012026-09-30jppfs_cor:TreasuryStockMember492802025-10-012026-09-30jppfs_cor:ValuationAndTranslationAdjustmentsMember492802025-10-012026-09-30jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember492802025-10-012026-09-30jppfs_cor:ForeignCurrencyTranslationAdjustmentMember492802025-10-012026-09-30jppfs_cor:NonControllingInterestsMember492802026-09-30jppfs_cor:ShareholdersEquityMember492802026-09-30jppfs_cor:CapitalStockMember492802026-09-30jppfs_cor:RetainedEarningsMember492802026-09-30jppfs_cor:TreasuryStockMember492802026-09-30jppfs_cor:ValuationAndTranslationAdjustmentsMember492802026-09-30jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember492802026-09-30jppfs_cor:ForeignCurrencyTranslationAdjustmentMember492802026-09-30jppfs_cor:NonControllingInterestsMember492802024-10-012025-09-30jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember492802025-09-30jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember492802025-09-30jpcrp_cor:UnallocatedAmountsAndEliminationMember492802025-10-012026-09-30jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMemberxbrli:pureiso4217:JPY